High Throughput Screening Market Share, Size, Trends, Industry Analysis Report: By Offerings (Consumables, Instruments, Services, Software), By Technology, By Application, By End-User, and By Region (North America, Europe, Asia-Pacific, Latin America, and

High Throughput Screening Market Share, Size, Trends, Industry Analysis Report: By Offerings (Consumables, Instruments, Services, Software), By Technology, By Application, By End-User, and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2024-2032

The global high throughput screening market size is expected to reach USD 74.53 billion by 2032, according to a new study by Polaris Market Research. The report “High Throughput Screening Market Size, Share, Trends, Industry Analysis Report: By Offerings (Consumables, Instruments, Services, Software), By Technology, By Application, By End-User, and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2024-2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

HTS plays a crucial role in drug discovery efforts within academic settings. Research organizations are utilizing these technologies to identify potential drug candidates and study their interactions with biological targets. This approach facilitates the screening of thousands to millions of compounds in a relatively short timeframe, enabling researchers to identify lead compounds with therapeutic potential more effectively. The adoption of HTS in translational research initiatives is also on the rise as institutions seek to bridge the gap between basic scientific discoveries and clinical applications.

High-throughput screening (HTS) technologies are experiencing a growing adoption among academia and research institutes worldwide, driven by their essential role in advancing various scientific endeavors. Academic institutions are leveraging HTS to conduct fundamental research across disciplines such as molecular biology, genetics, and biochemistry. These technologies enable researchers to screen large libraries of compounds or biomolecules efficiently, accelerating the pace of discovery in understanding biological mechanisms and pathways. By automating and scaling experimental processes, HTS empowers academic scientists to explore diverse hypotheses and conduct comprehensive studies that were previously impractical due to time and resource constraints.

In recent years, the expansion of drug repurposing strategies facilitated by high-throughput screening (HTS) has gained significant traction. HTS enables researchers to systematically screen large libraries of existing drugs against new biological targets or diseases, aiming to identify compounds that exhibit unexpected therapeutic benefits beyond their original indications. This approach leverages the wealth of pharmacological data and safety profiles already available for approved or investigational drugs, thereby offering a cost-effective and time-efficient pathway to discover novel therapeutic applications.

High Throughput Screening Market Report Highlights

• The consumables segment dominated the high-throughput screening market, driven by the continuous demand for reagents and assay kits, supported by expanding pharmaceutical R&D and government funding in life sciences.
• The drug discovery segment held the largest market share in 2023, driven by intensive pharmaceutical and biotechnology research efforts using HTS systems for efficient compound screening and lead identification, buoyed by government and research partnerships.
• North America dominated the market due to robust R&D investments in pharmaceuticals and biotechnology, focused on drug and biomarker development for chronic diseases, and increased healthcare expenditure.
• The Asia Pacific region expected to grow fastest over forecast period, fueled by a diverse patient base, rising demand for new therapeutics, and substantial R&D investments.
• The global key market players include Agilent Technologies, Inc., Aurora Biomed Inc., Axxam S.p.A., Biomat Srl, Bio-Rad Laboratories, Inc., BMG Labtech GmbH, Brand GmbH+Co KG, Charles River Laboratories, Corning Incorporated, Creative Biolabs, Crown Bioscience, and others.

Polaris Market Research has segmented the high throughput screening market report based on offerings, technology, application, end-user, and region:

High Throughput Screening, Offerings Outlook (Revenue - USD billion, 2019 - 2032)

Consumables

• Reagents & Assay Kits
• Laboratory Consumables

Instruments

• Liquid Handling Systems
• Detection Systems
• Imaging Systems
• Others

Services

Software

High Throughput Screening, Technology Outlook (Revenue - USD billion, 2019 - 2032)

Cell-based Assays

• 2D Cell Culture
• 3D Cell Culture

Old-based Technology

• Hydrogels
• Animal-derived Hydrogels

Matrigel

Collagen

• Synthetic Hydrogels
• Alginate/Agarose
• Inert Matrix/Solid Scaffolds
• Micropatterned Surfaces

Scaffold-free Technology

• Ultra-low Binding Plates
• Hanging-drop Plates
• Others
• Reporter-based Assays
• Perfusion Cell Culture

Lab-on-a-Chip Technology (LOC)

Label-free Technology

High Throughput Screening, Application Outlook (Revenue - USD billion, 2019 - 2032)

Drug Discovery

Biochemical Screening

Life Sciences Research

Others

High Throughput Screening, End-User Outlook (Revenue - USD billion, 2019 - 2032)

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Contract Research Organizations (CROs)

Others

High Throughput Screening, Regional Outlook (Revenue - USD billion, 2019 - 2032)

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Australia
• Rest of Asia Pacific

Latin America

• Argentina
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of Middle East & Africa